253 related articles for article (PubMed ID: 4994883)
1. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
Constans P; Parrot R; Coury C
Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
[No Abstract] [Full Text] [Related]
2. [Anatomic and bacteriologic testing of rifampicin effectiveness in treatment of pulmonary tuberculosis].
Morère P; Stain JP; Hubert J; Chauvet MC
Rev Tuberc Pneumol (Paris); 1970; 34(3):434-8. PubMed ID: 4994941
[No Abstract] [Full Text] [Related]
3. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
Delli Veneri F; Centrella G; Stefanelli R
Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
[No Abstract] [Full Text] [Related]
4. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
Golyshevskaia VI; El'shanskaia MP
Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
[No Abstract] [Full Text] [Related]
5. [Survival of tuberculous bacilli in combined treatments including rifampicin].
Kreis B; Pretet S
Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
[No Abstract] [Full Text] [Related]
6. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
Meissner G
Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
[No Abstract] [Full Text] [Related]
7. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
Homenko AG; Ciukanov VL
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
[TBL] [Abstract][Full Text] [Related]
9. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
Lesobre R; Frey N
Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
[No Abstract] [Full Text] [Related]
10. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
Pines A; Raafat H; Siddiqui GM
J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
[No Abstract] [Full Text] [Related]
11. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Mkrtchian SV; Ushkin VV
Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
[No Abstract] [Full Text] [Related]
12. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
N Engl J Med; 1970 Sep; 283(12):616-21. PubMed ID: 4988918
[No Abstract] [Full Text] [Related]
13. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
[No Abstract] [Full Text] [Related]
14. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
Bialik IB; Klimenko MT
Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942
[No Abstract] [Full Text] [Related]
17. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
Kesztele V; Niederkofler J
Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
[No Abstract] [Full Text] [Related]
18. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
Wipf R
Rev Med Suisse Romande; 1979 Apr; 99(4):205-13. PubMed ID: 504855
[No Abstract] [Full Text] [Related]
20. Short-course treatment regimens for patients with tuberculosis.
Dutt AK; Stead WW
Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
